Does rheumatoid factor bind IgG Fc and drive immune-complex–mediated inflammation?

Rheumatoid factor (RF) is a primary driver of the chronic inflammatory cycle in autoimmune conditions, functioning through highly specific biochemical interactions with the body's own antibodies.

Mechanisms of antibody binding

Rheumatoid factor is an autoantibody—most commonly of the IgM class—specifically designed to target the constant (Fc) portion of immunoglobulin G (IgG).

• Structural specificity: High-resolution X-ray crystallography has mapped the binding site to the CH2-CH3 domain interface of the IgG molecule. Specifically, RF CDRs (complementarity-determining regions) engage with key amino acid residues like Leu432 and His435 on the IgG Fc region.
• Conformational triggers: While native IgG may partially hide these binding sites, conformational changes caused by heat, aggregation, or the binding of IgG to its own target antigens "expose" the CH2-CH3 elbow, allowing RF to latch on and initiate complex formation.

Promotion of immune complexes and inflammation

The binding of RF to IgG creates large, stable circulating immune complexes (CICs) that act as potent inflammatory stimuli rather than inert markers.

• Fc receptor activation: These RF-IgG complexes crosslink Fcγ receptors (FcγRs) on the surface of myeloid cells like macrophages and monocytes. This crosslinking triggers the NF-κB and MAPK signaling pathways, leading to the massive release of pro-inflammatory cytokines, including TNF-α, IL-1β, and IL-6.
• Complement recruitment: The IgM-RF-IgG lattice is exceptionally efficient at activating the classical complement pathway. This produces anaphylatoxins such as C5a, which further recruit inflammatory cells to the site of tissue involvement (e.g., the synovium in RA), sustaining the inflammatory state.
• Clinical correlation: Studies consistently show that the presence of these complexes correlates with elevated C-reactive protein (CRP) and more aggressive systemic disease.

Bottom line

The claim is fully supported by science. Rheumatoid factor binds the Fc portion of IgG to form circulating immune complexes that sustain chronic inflammation through complement activation and the triggering of pro-inflammatory cytokine cascades.